Mouna EL Fane1, Houda EL Fane2, Mustapha Sodqi3 and Imane Sellam1
1Faculty of Medicine and Pharmacy, University Ibn zohr, Agadir, Morocco
2Faculty of Sciences, University Chouaib Doukkali, EL Jadida, Morocco
3Faculty of Medicine and Pharmacy, University Hassan, Casablanca, Morocco
*Corresponding author: El Fane Mouna, Faculty of Medicine and Pharmacy, University Ibn zohr, Agadir, Morocco, Tel:
212 660832362; E-mail: elfanemouna@gmail.com
Citation: Mouna EL Fane, Houda EL Fane, Mustapha Sodqi, Imane Sellam (2020) Te Epidemiology, Diagnosis and
Treatment of Coronavirus Disease 2019 (COVID-19): A Review. J Infect Dis Pathog 3: 105
In December 2019, a new coronavirus, named SARS-CoV-2, has emerged from China causing pneumonia outbreaks first in the Wuhan region
and have now spread worldwide becoming an emergency of major international concern. Te novel coronavirus SARS-CoV-2 (Covid-19) is one of
the causes of respiratory infections that can spread to other people through respiratory particles, and can cause symptoms such as fever, dry cough,
shortness of breath, anorexia, fatigue. In addition to the respiratory system, this virus can infect the digestive, neurological, cardiovascular and the
haematological system. Diagnosis is based on the Reverse transcriptase polymerase chain reaction testing and CT scan. Te imaging performance
on chest CT scans from COVID-19 patients mainly manifested as bilateral ground-glass opacities in the lung periphery. Mortality is associated
with older age, comorbidities, higher d-dimer, C-reactive protein concentrations and lower lymphocyte counts. Treatments, including antiviral
agents, chloroquine and hydroxychloroquine, corticosteroids, immunoglobulins. Tis paper reviews the literature on all available information
about the epidemiology, diagnosis and treatments of COVID-19.
Keywords: Coronavirus Disease 2019; COVID-19; SARS-CoV-2; Clinical Manifestation; Laboratory Examination
